The report anti-malarial drugs market drug type (quinine, chloroquine, amodiaquine, pyrimethamine, and others.), by malaria type (plasmodium falciparum, plasmodium vivax, plasmodium malariae, and plasmodium ovale.), by mechanism of action (resistance, and prevention.), by distribution channel type (hospitals & retail pharmacy, e-commerce, and others.) by region (North America, Europe, Asia Pacific, Middle East & Africa and South America) is expected to reach US$ XX Mn by 2027 to exhibit a CAGR of XX % during a forecast period.
Malaria is the disease occurs in the tropical, subtropical and temperate regions of the world. Effective antimalarial therapy not only decreases the illness and mortality of malaria, but also reduces the peril of resistance to antimalarial drugs. Malaria is the disease caused owing to the parasite known as Plasmodium, which belongs to the group of Protozoans. The increasing prevalence of the malarial disease globally is likely to boost the demand of anti-malarial drugs market.
The demand for the global anti-malarial drugs market is growing due to the massive growth of the healthcare industry across the globe. Further, increasing alertness about early symptoms, constant monitoring and easy availability of therapeutics is also major growth factors of the global anti-malarial drugs market during the forecast period. However, the side effects of the anti-malarial medications may hinder the growth of the global anti-malarial drugs market during the forecast period.
Quinine drug type is leading the market.
Quinine drug type is leading the market, owing to the more useful drug for malaria as well as it has fewer side effects as compared to other drugs such as antifolates, artemisinin derivatives, and antimicrobials. Quinine contains the usage of malaria, due to Plasmodium falciparum that is resistant to chloroquine when artesunate is not available. Quinine’s main advantage is for the treatment of malaria. Quinine is not used to prevent malaria, but it is used to kill the organism responsible for malaria disease. Quinine is used to treat malaria in the form of pills.
The E-commerce segment is expected to drive the global anti-malarial drugs market.
The E-commerce segment is expected to drive the global anti-malarial drugs market, owing to the consumer preference for using online worldwide. Some benefits of using the e-commerce are convenience & easiness, offer product datasheets, attract new customers with search engine visibility, comprise warranty information, decreasing cost of inventory management, and keep eye on consumers’ buying habit.
Maximize market research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the global anti-malarial drugs market. The report encompasses the market by different segments and region, providing an in-depth analysis of the overall industry, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics, and future opportunities that might exist in the global anti-malarial drugs market. The driving forces, as well as considerable restraints, have been explained in depth. In addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain global anti-malarial drugs market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Anti-Malarial Drugs Market”
Contact:
Vikas Godage
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
Manik Baug, Vadgaon Bk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607195908